Tuesday, December 27, 2022

Gambling associated risk-taking decision in cerebellar ataxia

›
Ruo-Yah Lai Natasha A. Desai Christian J. Amlang Chi-Ying R. Lin Tiffany X. Chen Michael J. Minyetty Nadia Amokrane Sheng-Han Kuo;  Parkinso...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc.

›
NEW YORK, Dec. 26, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. ("Des...

The psychosocial situation of families caring for children with rare diseases during the COVID-19 pandemic: results of a cross-sectional online survey

›
Lydia Rihm, Mareike Dreier, Farhad Rezvani, Silke Wiegand-Grefe & Jörg Dirmaier; Orphanet J Rare Dis 17, 449 (2022). doi:10.1186/s13023...

Social concepts and the cerebellum: behavioural and functional connectivity signatures in cerebellar ataxic patients

›
Lopes da Cunha Pamela, Fittipaldi Sol, González Campo Cecilia, Kauffman Marcelo, Rodríguez-Quiroga Sergio, Yacovino Darío Andrés, Ibáñez Agu...
Saturday, December 24, 2022

Protection of dystrophic muscle cells using Idebenone correlates with the interplay between calcium, oxidative stress and inflammation

›
Amanda Harduim Valduga, Daniela Sayuri Mizobuti, Fernanda dos Santos Rapucci Moraes, Rafael Dias Mâncio, Luis Henrique Rapucci Moraes, Túlio...

Astrocytic mitochondrial frataxin—A promising target for ischemic brain injury

›
Hazra, R, Novelli, EM, Hu, X.; CNS Neurosci Ther. 2022; 00: 1- 6. doi:10.1111/cns.14068  In the ischemic brain, hypoxia leads to mitochondri...
Thursday, December 22, 2022

Study traces shared and unique cellular hallmarks found in 6 neurodegenerative diseases

›
ScienceDaily, 21 December 2022. Arizona State University.  In a study appearing in the current issue of Alzheimer's & Dementia: The ...

Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseases

›
Carol J. Huseby, Elaine Delvaux, Danielle L. Brokaw, Paul D. Coleman; Alzheimer's & Dementia, 2022; DOI: 10.1002/alz.12880   We repo...
Saturday, December 17, 2022

Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)

›
Pandolfo M, Reetz K, Darling A, Rodriguez de Rivera FJ, Henry PG, Joers J, Lenglet C, Adanyeguh I, Deelchand D, Mochel F, Pousset F, Pascual...
Thursday, December 15, 2022

Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation

›
Arnoldi M, Zarantonello G, Espinoza S, Gustincich S, Di Leva F, Biagioli M.; Methods Mol Biol. 2022;2434:63-87. doi: 10.1007/978-1-0716-2010...